» Authors » Montserrat Butjosa

Montserrat Butjosa

Explore the profile of Montserrat Butjosa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 318
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aibar J, Martinez-Florensa M, Castro P, Carrasco E, Escoda-Ferran C, Fernandez S, et al.
J Crit Care . 2015 Jun; 30(5):914-9. PMID: 26031813
Purpose: Soluble forms of CD5 and CD6 lymphocyte surface receptors (sCD5 and sCD6) are molecules that seem to prevent experimental sepsis when exogenously administered. The aim of this study was...
2.
Aibar J, Castro P, Espinosa G, Fernandez S, Hernandez C, Rinaudo M, et al.
Shock . 2015 Feb; 43(6):556-62. PMID: 25643015
Purpose: Decreased ADAMTS-13 (A Disintegrin and Metalloprotease with a ThromboSpondin type 1 motif, member 13) seems to be associated with a poor prognosis in sepsis. However, its role in different...
3.
Alba M, Garcia-Martinez A, Prieto-Gonzalez S, Tavera-Bahillo I, Corbera-Bellalta M, Planas-Rigol E, et al.
Medicine (Baltimore) . 2014 Sep; 93(5):194-201. PMID: 25181312
Giant cell arteritis (GCA) is a relapsing disease. However, the nature, chronology, therapeutic impact, and clinical consequences of relapses have been scarcely addressed. We conducted the present study to investigate...
4.
Alba M, Garcia-Martinez A, Prieto-Gonzalez S, Espigol-Frigole G, Butjosa M, Tavera-Bahillo I, et al.
Semin Arthritis Rheum . 2013 Dec; 43(6):772-7. PMID: 24315461
Objective: To determine whether concomitant treatment with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) is associated with changes in the outcome of patients with giant cell arteritis (GCA)....
5.
Garcia-Martinez A, Arguis P, Prieto-Gonzalez S, Espigol-Frigole G, Alba M, Butjosa M, et al.
Ann Rheum Dis . 2013 Jul; 73(10):1826-32. PMID: 23873881
Background: Aortic structural damage (ASD) may complicate the course of patients with giant cell arteritis (GCA). However the frequency and outcome of ASD has not been assessed in long term...
6.
Corbera-Bellalta M, Garcia-Martinez A, Lozano E, Planas-Rigol E, Tavera-Bahillo I, Alba M, et al.
Ann Rheum Dis . 2013 Apr; 73(3):616-23. PMID: 23625984
Background: Search for therapeutic targets in giant-cell arteritis (GCA) is hampered by the scarcity of functional systems. We developed a new model consisting of temporal artery culture in tri-dimensional matrix...
7.
Alba M, Espigol-Frigole G, Prieto-Gonzalez S, Tavera-Bahillo I, Garcia-Martinez A, Butjosa M, et al.
Curr Neuropharmacol . 2012 Mar; 9(3):437-48. PMID: 22379458
The central nervous system (CNS) may be involved by a variety of inflammatory diseases of blood vessels. These include primary angiitis of the central nervous system (PACNS), a rare disorder...
8.
Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M, et al.
Ann Rheum Dis . 2012 Jan; 71(7):1170-6. PMID: 22267328
Background: Necroscopic and surgical studies have suggested that giant cell arteritis (GCA) may target the aorta and its main branches. Imaging techniques are able to detect large vessel vasculitis (LVV)...
9.
Garcia-Martinez A, Hernandez-Rodriguez J, Espigol-Frigole G, Prieto-Gonzalez S, Butjosa M, Segarra M, et al.
Arthritis Care Res (Hoboken) . 2010 Jun; 62(6):835-41. PMID: 20535794
Objective: To assess the clinical relevance of increased circulating cytokines in patients with giant cell arteritis (GCA) after long-term followup. Methods: We performed a cross-sectional evaluation of 54 patients with...
10.
Cid M, Hernandez-Rodriguez J, Espigol-Frigole G, Butjosa M, Prieto-Gonzalez S, Garcia-Martinez A, et al.
Arthritis Rheum . 2009 Aug; 60(9):2853-4. PMID: 19714642
No abstract available.